 long-term remiss chronic hepat alpha-interferon therapi object remiss chronic hepat alpha-interferon therapi long durat design cohort studi set clinic center nation health tertiari referr center patient sixty-four patient chronic hepat alpha-interferon main outcom measur patient frequent examin determin serum liver biochem test hepat viru hbv marker hepat surfac antigen hbsag hepat antigen hbeag hbv dna blot hybrid polymeras chain reaction result patient chronic hepat alpha-interferon treatment loss hbeag improv serum aminotransferas year mean year follow-up patient reappear hbeag abnorm serum aminotransferas year therapi patient detect hbeag hbv dna blot hybrid serum asymptomat liver diseas minim elev serum aminotransferas thirteen patient neg hbsag year mean year loss hbeag patient hbv dna detect blot hybrid patient hbsag posit hbv dna serum polymeras chain reaction hbsag-neg patient viral genom method sequenti sampl hbv dna polymeras chain reaction time test result hbsag neg conclus remiss chronic hepat alpha-interferon long durat patient loss hbsag evid residu viru replic